Corcept Therapeutics (CORT) is up 28.6%, or $9.67 to $43.49.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORT:
- Corcept Therapeutics trading resumes
- Corcept Therapeutics up 43% to $48.35 after FDA approves Lifyorli
- FDA approves Corcept Therapeutics’ Lifyorli for certain cancers
- Corcept Therapeutics jump 10% after FDA approves Lifyorli cancer treatment
- Corcept Therapeutics trading halted, volatility trading pause